%. SG&A in terms of % to revenue improved from 6.8% in Q1 2021 to 5.8% in Q1 2022. Core operating profit (defined as Earnings before Interests and Taxes exclude interest income, gain (loss) on exchange
% Administrative expenses (39.92) (37.10) 2.82 -7.06% Profit from operating activities 113.57 53.11 (60.47) -53.24% Share of profit on investments in associate 0.13 0.71 0.58 443.81% Finance costs (0.34) (0.23) 0.11
operating profit (defined as Earnings before Interests and Taxes exclude interest income, gain (loss) on exchange rate and other irregular items) reached Baht 762.3 million in Q1 2023; a 46.3% increase from
21.8% 5.5% 2.6% Service & Administrative expenses (59.91) -8.4% (86.99) -10.5% (66.14) -7.9% -24.0% 10.4% Operating profit 119.28 16.7% 87.32 10.5% 117.67 14.0% 34.8% -1.4% Other income 44.82 6.3% 59.08
2018 and Annual Report of the Board of Directors in relation to the Company operating result in respect of the year 2018, which is subject to the approval of the Annual General Meeting of Shareholders No
production. Moreover, our main customer also lowered their production plan for the Combined Harvester which inline to a decline in sales of our screw flight and also lessen production of tractor in small model
at 0.35 times. Cash Flow As of December 31th, 2018, the Company had cash paid in operating activities around 31.00 million baht, increased about 191.97 baht, and had cash paid in investing activities
Limited (“Company”) and its subsidiaries would like to clarify the operating results for the year ended December 31, 2018 according to consolidated financial statements. In 2018 the Company had total
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company
Y2018 Company Performance MDX Public Company Limited (“MDX”) would like to explain major factors that affect Y2018 consolidated operating results as follows: ▪ MDX has THB 137.76 million of land-sale